Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Brain Neoplasms 2Neoplasm Metastasis 1Multiple Myeloma 1Lymphoma 1Leukemia 1Hematologic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms, Male 1Breast Neoplasms 1

Interventions

Fulvestrant 34Specimen Handling 31Letrozole 30Paclitaxel 23pembrolizumab 19Carboplatin 19ribociclib 18exemestane 18Capecitabine 17Trastuzumab 16Tamoxifen 16Magnetic Resonance Spectroscopy 16palbociclib 15Anastrozole 15Biopsy 14trastuzumab deruxtecan 13abemaciclib 13pertuzumab 11Radiotherapy 11Cyclophosphamide 9inavolisib 8elacestrant 8olaparib 7Taxes 7Standard of Care 7Radiation 7Mastectomy, Segmental 7Goserelin 7130-nm albumin-bound paclitaxel 7giredestrant 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Neoplasms × Mental Status and Dementia Tests × 30 days × Clear all
NCT00609791 2026-06-04

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients of Different Ages With Metastatic Breast Cancer

City of Hope Medical Center

Phase 2 Active not recruiting
40 enrolled 16 charts
Breast

Breast Neoplasms, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡